{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:48:29Z","timestamp":1782121709505,"version":"3.54.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    Depression and anxiety are among the most common comorbidities in individuals with Parkinson\u2019s disease (PD). Yet their prevalence and contributing factors in Saudi Arabia are poorly examined. This study aimed to estimate the prevalence of depression and anxiety among patients with PD in Saudi Arabia, along with contributors, demographics, and clinical correlates. A cross-sectional study was conducted in Riyadh, Saudi Arabia, in which 130 patients diagnosed with PD completed the validated Arabic versions of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) to ascertain the presence of depression and anxiety, respectively. Sociodemographic, patient-related factors, and clinical data were also collected and analyzed in conjunction with the aforementioned scales using univariate and multivariable logistic regression. Depression and anxiety were present in 67.7% and 62.3% of participants, respectively. Compared with the age group 41\u201350 years, the 51\u201360 and 61\u201370 groups were less likely to be depressed or anxious (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.013 and\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.008). Lower education (high school or less) was associated with both depression and anxiety (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.021 and\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.017). Anxiety (GAD-7) was associated with a history of major depressive disorder (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    =\u2005.003). Longer PD duration was associated with higher odds of both anxiety and depression (\n                    <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                    \u2264\u2005.001). Our study shows a high prevalence of anxiety and depression in patients with PD, particularly among those with longer disease duration and lower educational attainment. Routine neuropsychological screening and early multidisciplinary care are warranted.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048538","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:00:18Z","timestamp":1777629618000},"page":"e48538","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Depression and anxiety among patients with Parkinson\u2019s disease: A cross-sectional study in a Saudi population"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-4511","authenticated-orcid":false,"given":"Sohaila","family":"Alshimemeri","sequence":"first","affiliation":[{"name":"Neurology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Aljaffer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia"},{"name":"SABIC Psychological Health Research and Applications Chair (SPHRAC), Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayedh H.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia"},{"name":"SABIC Psychological Health Research and Applications Chair (SPHRAC), Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf F.","family":"Alshammari","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Eradah Complex for Mental Health, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif","family":"Alsaber","sequence":"additional","affiliation":[{"name":"Department of Neurology, King Abdulaziz Medical City, Ministry of National Guard and Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakan S.","family":"Alromayan","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H.","family":"Almadani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/PL00007856","article-title":"The heterogeneity of idiopathic Parkinson\u2019s disease.","volume":"249","author":"Foltynie","year":"2002","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"R3-20260622","article-title":"Estimation of the 2020 global population of Parkinson\u2019s disease (PD) [Abstract].","volume":"35","author":"Maserejian","year":"2020","journal-title":"Mov Disord"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12889-023-15018-x","article-title":"The burden of Parkinson\u2019s disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019.","volume":"23","author":"Safiri","year":"2023","journal-title":"BMC Public Health"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000442283","article-title":"Parkinson\u2019s disease in the gulf countries: an updated review.","volume":"74","author":"Alamri","year":"2015","journal-title":"Eur Neurol"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","article-title":"Depression rating scales in Parkinson\u2019s disease: critique and recommendations.","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2021.10.022","article-title":"Trends in the incidence and DALYs of anxiety disorders at the global, regional, and national levels: estimates from the global burden of disease study 2019.","volume":"297","author":"Xiong","year":"2022","journal-title":"J Affect Disord"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0253-7176.70510","article-title":"Depression: the disorder and the burden.","volume":"32","author":"Reddy","year":"2010","journal-title":"Indian J Psychol Med"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0022-3999(71)90027-4","article-title":"Psychosomatic aspects of Parkinsonism.","volume":"15","author":"Crown","year":"1971","journal-title":"J Psychosom Res"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s41983-020-00253-5","article-title":"Depression and anxiety among patients with Parkinson\u2019s disease: frequency, risk factors, and impact on quality of life.","volume":"56","author":"Khedr","year":"2020","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease.","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"104749","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson\u2019s disease: a systematic review and meta\u2011analysis of 129 studies.","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","article-title":"Anxiety disorders in Parkinson\u2019s disease: prevalence and risk factors.","volume":"25","author":"Dissanayaka","year":"2010","journal-title":"Mov Disord"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13803395.2015.1087466","article-title":"Prevalence of depression in Parkinson\u2019s disease in a Lebanese tertiary clinic.","volume":"38","author":"Ghaddar","year":"2016","journal-title":"J Clin Exp Neuropsychol"},{"key":"R15-20260622","first-page":"26","article-title":"Clinical and neuropsychological profile in idiopathic Parkinson\u2019s disease: about an Algerian hospital series.","volume":"21","author":"Belarbi","year":"2022","journal-title":"IOSR J Dent Med Sci"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"S961","DOI":"10.1192\/j.eurpsy.2023.2041","article-title":"Anxiety and depression in tunisian patients with Parkinson\u2019s disease.","volume":"66","author":"Kolsi","year":"2023","journal-title":"Eur. Psychiatr"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fneur.2018.00170","article-title":"Non-motor symptoms of Parkinson\u2019s disease and their impact on quality of life in a cohort of moroccan patients.","volume":"9","author":"Tibar","year":"2018","journal-title":"Front Neurol"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"e30246","DOI":"10.5812\/ircmj.30246","article-title":"Disease-related variables and depression among Iranian patients with Parkinson disease.","volume":"17","author":"Shakeri","year":"2015","journal-title":"Iran Red Crescent Med J"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/NDT.S493629","article-title":"The prevalence of depression among Parkinson\u2019s disease patients in Saudi Arabia: a cross-sectional study.","volume":"21","author":"Al-Qahtani","year":"2025","journal-title":"NDT"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4236\/ojpsych.2014.42016","article-title":"Mental health care in Saudi Arabia: past, present and future.","volume":"04","author":"Koenig","year":"2014","journal-title":"OJPsych"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hsw\/25.1.9","article-title":"Culturally sensitive social work practice with Arab clients in mental health settings.","volume":"25","author":"Al-Krenawi","year":"2000","journal-title":"Health Soc Work"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12991-017-0155-1","article-title":"An arabic translation, reliability, and validation of patient health questionnaire in a Saudi sample.","volume":"16","author":"AlHadi","year":"2017","journal-title":"Ann Gen Psychiatry"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1067\/mob.2000.106580","article-title":"Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD patient health questionnaire obstetrics-gynecology study.","volume":"183","author":"Spitzer","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/mds.22233","article-title":"Anxiety rating scales in Parkinson\u2019s disease: critique and recommendations.","volume":"23","author":"Leentjens","year":"2008","journal-title":"Mov Disord"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mdc3.12272","article-title":"Associations and implications of low health literacy in Parkinson\u2019s disease.","volume":"3","author":"Fleisher","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0891988713481269","article-title":"Barriers to mental health care utilization in Parkinson\u2019s disease.","volume":"26","author":"Dobkin","year":"2013","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0041-1722840","article-title":"Anxiety in Parkinson\u2019s disease: correlation with depression and quality of life.","volume":"12","author":"Upneja","year":"2021","journal-title":"J Neurosci Rural Pract"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2011.02.023","article-title":"Anxiety and depression severity are related to right but not left onset Parkinson\u2019s disease duration.","volume":"305","author":"Foster","year":"2011","journal-title":"J Neurol Sci"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4103\/jfmpc.jfmpc_2288_22","article-title":"Association of depression with disease duration, quality of life and adherence in Parkinson\u2019s disease: a cross sectional study.","volume":"12","author":"Samanta","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"R32-20260622","doi-asserted-by":"crossref","first-page":"1339716","DOI":"10.3389\/fneur.2024.1339716","article-title":"Age and gender differences in non-motor symptoms in people with Parkinson\u2019s disease.","volume":"15","author":"Maas","year":"2024","journal-title":"Front Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:01:42Z","timestamp":1782118902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":31,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048538","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2025-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}